BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

The study, led by Dr. Lopa Mishra and published in Cell Reports, provides new mechanistic evidence for role of BF-114 target β2-spectrin in obesity, MASLD, MASH, and HCC The findings suggest that targeting β2-spectrin with BF-114 can prevent the progression of liver diseases New data builds on earlier studies and further supports BF-114's potential to address major unmet needs in treating obesity-related liver diseases Dr. Lopa Mishra, a globally recognized expert in liver disease, has joined BullFrog AI's ...